ClinicalTrials.Veeva

Menu

Remineralizing Potential of Biomimetic Scaffolds on Enamel White Spot Lesions

H

Hams Hamed Abdelrahman

Status

Not yet enrolling

Conditions

White Spot Lesion

Treatments

Other: CCP-ACP " +ve control " Casein phosphopeptide amorphous calcium phosphate
Other: Ph-chi phosphorylated - nano-chitosan
Other: Curodont repair Self- assembling peptide P11-4

Study type

Interventional

Funder types

Other

Identifiers

NCT05584878
biomimetic scaffolds _2022

Details and patient eligibility

About

The modern concept in caries treatment focuses on the non-invasive approach and on the biomimetic remineralization of early non-cavitated white spot carious lesions. Recently developed biomimetic scaffolds attempt to remineralize the dental tissues and are more regenerative than reparative.

Enrollment

63 estimated patients

Sex

All

Ages

18 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who at least have 1 white spot lesion.
  • No systemic diseases or taking any medication affecting salivary flow.
  • Patients with good oral hygiene measures.
  • Patients with moderate caries risk assessment.
  • Post orthodontic WSLs with International Caries Detection and Assessment System (ICDAS II) scoring criteria (1-2).

Exclusion criteria

  • Participant in another trial.
  • Developmental non carious lesion (enamel hypoplasia and dental fluorosis).
  • Presence of abnormal oral disease, or medically compromised patients.
  • Participants who had evidence of reduced salivary flow or significant tooth wear.
  • Allergy to milk products or other drug allergies.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

63 participants in 3 patient groups

Group I
Experimental group
Treatment:
Other: Curodont repair Self- assembling peptide P11-4
Group II
Experimental group
Treatment:
Other: Ph-chi phosphorylated - nano-chitosan
Group III
Active Comparator group
Treatment:
Other: CCP-ACP " +ve control " Casein phosphopeptide amorphous calcium phosphate

Trial contacts and locations

1

Loading...

Central trial contact

Eman M Elsayed, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems